This new research sheds light on shared and subtype-specific genetic variations and points to potential targets ...

HT2C functional selectivity and Phase 1 clinical data - NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inc. (NASDAQ: DRUG), a ...

Poster presentations on Phase 2a trial seizure biomarker, preclinical, and Phase 1 clinical dataBOSTON and SAN DIEGO, Nov. 14 ...

Millions of people globally live with epilepsy, a neurological disorder causing unpredictable seizures. While the exact ...

Among these considerations is the ketogenic diet, which is often used by individuals with epilepsy to help manage their ...

Could the origins of Parkinson's and Alzheimer's lie in the gut? Uncover the gut-brain link and its impact on mental health ...

Researchers combine gene therapy with optogenetics to curb abnormal neural activity and prevent seizure-like activity in neurons.

The study will test spider venom molecules against brain tissue made from the blood of individual epilepsy patients.

Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...

Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted ...

Marinus Pharmaceuticals, a company based in Radnor that focuses on therapies for seizures, is laying off nearly half of its ...